Related Experiment Videos
Foveal ablation for subfoveal choroidal neovascularization
1Palo Alto Medical Foundation, CA 94301.
Ophthalmology
|September 1, 1989
Summary
Laser photocoagulation effectively eliminated subfoveal choroidal neovascularization (SFCN) in most treated eyes, preserving visual fields and improving vision. This treatment shows promise for select SFCN cases with early-stage disease.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Neovascularization
Background:
- Subfoveal choroidal neovascularization (SFCN) significantly impairs central vision.
- Untreated SFCN often leads to irreversible vision loss.
Purpose of the Study:
- To evaluate the efficacy of laser photocoagulation for treating subfoveal choroidal neovascularization (SFCN).
- To assess visual acuity and visual field outcomes after foveal photocoagulation in SFCN patients.
Main Methods:
- Laser photocoagulation targeting the foveal avascular zone was applied to SFCN in the second eye of 13 patients.
- Patients had untreated SFCN in their first eye and recent-onset SFCN (≤1 DD size) in the treated second eye.
- Visual acuity and visual fields were compared between treated and untreated fellow eyes.
Main Results:
- SFCN was eliminated in 76.9% (10/13) of treated eyes for 3 to 30 months.
- Treated eyes demonstrated significantly better visual fields and subjective vision compared to untreated eyes.
- Snellen visual acuities in treated eyes ranged from 20/70 to 20/400.
Conclusions:
- Foveal photocoagulation can be a beneficial treatment for selected cases of SFCN.
- The procedure is particularly useful for SFCN with small neovascular nets and pre-existing poor visual acuity.